Igf-Ir Inhibition Effect On A Yes/Sfk Bypass Resistance Pathway: Rational Basis For Cotargeting Igf-Ir And Yes/Sfk Kinase In Rhabdomyosarcoma.
JOURNAL OF CLINICAL ONCOLOGY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2014)